Last Updated: October 4, 2025
Analyzing Management
Leadership within public companies plays a crucial role for hedge funds and asset managers during both initial due diligence and continuous risk assessment. ManagementTrack offers a consistent framework that eliminates distractions, highlighting notable strengths and weaknesses, identifying warning signs and positive indicators, and drawing a clear connection between CEO choices and investment performance.
CEO Coric’s record of clinical failures may overshadow his capital raising prowess
Analysis of Biohaven CEO Vladimir Coric
While an elite capital raiser, Vladimir Coric’s record of late-stage clinical failures and regulatory challenges may leave him poorly positioned to navigate the company’s high-risk pipeline to successful approval.
Management evaluated Vladimir Coric’s track record and skillset against the following key factors for BHVN:
- Advancing novel degrader platforms into pivotal trials.
- Executing high-risk pivot of taldefgrobep into obesity.
- Navigating complex FDA review for Vyglxia approval.
- Managing high cash burn to fund the pipeline.
Vladimir Coric’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
Given the stark contrast between his success in financing and deal-making versus the serial clinical failures, does Coric prioritize securing capital to continue trials over making the disciplined, objective decision to terminate a scientifically unpromising program?
Question #2
In light of the investor lawsuit and the divergence between his optimistic narrative and the market’s view of repeated setbacks, does Coric’s visionary salesmanship prevent him from objectively assessing clinical data and pivoting strategy before a program reaches a public, value-destroying failure?
Question #3
Does Coric’s past involvement in both a singular blockbuster success and numerous high-profile neuroscience failures make him more resilient in pursuing high-risk assets, or does it create a blind spot that prevents him from recognizing a recurring pattern of failure in his development strategy?
Why Do Investors Use ManagementTrack?
How does ManagementTrack evaluate Vladimir Coric’s leadership at BHVN?
Through proprietary career analysis and interviews with former colleagues, ManagementTrack establishes an executive’s track record, core competencies, and potential weaknesses. This profile is then measured against BHVN’s most critical challenges: advancing novel degrader platforms into pivotal trials, executing a high-risk pivot into obesity, navigating a complex FDA review, and managing the company’s high cash burn to fund its pipeline.
What additional proprietary methods does ManagementTrack utilize to forecast company performance based on executive actions?
ManagementTrack utilizes proprietary models to detect and flag unusual instances of executive evasion during earnings call Q&A. The platform also scrutinizes all insider transactions to identify outlier trades that can predict future stock over or underperformance. When combined with the ManagementTrack Rating—a predictive 1-10 score for every executive—these tools give investors a clear, data-driven view on how leadership will likely impact company performance.
What is the scope of ManagementTrack’s coverage?
ManagementTrack provides real-time analysis on the c-suite of every publicly traded company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
Verified Career History by ManagementTrack for Vladimir Coric
Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
Biohaven Ltd. 10Q
Biohaven Ltd. 10K
Biohaven Ltd. Earnings Calls
Biohaven Ltd. Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
